The IA-2 is a major
autoantigen of
type 1 diabetes belonging to the
protein tyrosine phosphatase family. We report on the humoral autoimmunity to an alternatively-spliced variant of IA-2 (IA-2 variant) and autoimmune-mediated diabetes age of onset association with
IA-2 autoantibody epitope specificities, in 144 recent-onset patients with
type 1 diabetes and 54 GAD
autoantibody-positive patients with
type 2 diabetes. The cytoplasmic domain of IA-2 (IA-2ic) detected a somewhat greater proportion of patients expressing
autoantibodies than IA-2 variant (56%vs. 52% of patients with
type 1 diabetes and 17%vs. 9% of GAD
autoantibody-positive patients with
type 2 diabetes). Conversely, only 1% of IA-2 variant
autoantibody-positive patients failed to react to IA-2ic construct. Among 80 patients with
type 1 diabetes who were positive for
autoantibodies to IA-2ic, 8% recognized the juxtamembrane region (JM, representing
amino acids 601-629) only, 64% bound the
protein tyrosine phosphatase (PTP)-like domain of IA-2 only, and 29% bound both JM and PTP
epitopes.
Autoantibodies to the PTP-like domain were prevalent in children and adolescents with
type 1 diabetes. The age of disease onset in patients with IA-2JM
autoantibodies only, was significantly higher than those in patients reacted with the PTP-like domain of IA-2 (P< 0.02). Among GAD
autoantibody-positive patients with
type 2 diabetes reacted with IA-2ic, 44% bound the JM region only, and 33% bound
epitopes in the PTP-like domain only; 22% had
autoantibodies to both regions. The frequency of GAD
autoantibody-positive patients with
type 2 diabetes positive for
autoantibodies to the JM region only, was significantly higher than that in patients with
type 1 diabetes (P< 0.01). IA-2PTP
autoantibodies were significantly associated with
HLA-DR4, while the additional reactivity to IA-2JM was associated with
HLA-DR9 allele. These results suggest that
autoantibody recognition of IA-2
epitopes in
autoimmune diabetes is associated with age of disease onset, which may reflect the intensity of the beta-cell destruction process.